Cargando…

Evaluation of endolaser thermoablation of the small saphenous vein under local anesthesia

BACKGROUND: The small saphenous vein (SSV) is affected in 15% of chronic venous insufficiency (CVI) cases. Conventional surgery is the standard technique for treatment of SSV insufficiency, but sural nerve injury is a complication of great concern. Endovenous laser ablation is a surgical technique f...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Filipe Cézar Bertassoni, de Araujo, Walter Jr. Boim, Brandao, Adriana Buechner de Freitas, Mazzoni, Camila de Almeida, Erzinger, Fabiano Luiz, Caron, Filipe Carlos, Ruggeri, Viviane Gomes Milgioransa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336979/
https://www.ncbi.nlm.nih.gov/pubmed/34394206
http://dx.doi.org/10.1590/1677-5449.200215
Descripción
Sumario:BACKGROUND: The small saphenous vein (SSV) is affected in 15% of chronic venous insufficiency (CVI) cases. Conventional surgery is the standard technique for treatment of SSV insufficiency, but sural nerve injury is a complication of great concern. Endovenous laser ablation is a surgical technique for treatment of CVI that is considered likely to reduce morbidity and mortality. OBJECTIVES: To evaluate patients with CVI undergoing endovenous laser ablation of the SSV at least 30 days after the procedure. METHODS: We analyzed 54 lower extremities in 46 patients scheduled for 1470-nm endovenous laser ablation under local anesthesia to treat CVI in a tertiary hospital. Patients were evaluated preoperatively, intraoperatively, and postoperatively over 30 days with clinical examination, physical examination, and ultrasound. RESULTS: In the 54 lower extremities treated, there was a significant difference (p < 0.003) in terms of reduction in the diameter of treated veins (6.37 mm preoperatively and 5.15 mm on the 30th postoperative day) and improvement in the venous clinical severity score (VCSS) (means of 8.02 preoperative and 6.11 on the 30th postoperative day) (95%CI, 5.01—7.21) (p < 0.02). Postoperative complications such as paresthesia and phlebitis were present and diagnosed in 5 and 3 patients, respectively, but did not affect their quality of life or routine activities. CONCLUSIONS: Intravenous laser ablation of the SSV proved to be safe and effective for reducing clinical symptoms and improving quality of life.